首页> 外文期刊>Journal of International Medical Research >Short-term clinical and oncological outcomes after single-incision plus one-port laparoscopic surgery for rectosigmoid cancer: a retrospective clinical analysis of 30 cases
【24h】

Short-term clinical and oncological outcomes after single-incision plus one-port laparoscopic surgery for rectosigmoid cancer: a retrospective clinical analysis of 30 cases

机译:单切割后的短期临床和肿瘤性结果加上直接腹腔镜手术,用于矫直物癌:回顾性临床分析30例

获取原文
           

摘要

Objective To evaluate the safety and feasibility of single-incision laparoscopic surgery+1 (SILS+1) radical resection of sigmoid and upper rectal cancer. Methods The clinical data of 30 consecutive patients with sigmoid and upper rectal cancer who underwent SILS+1 radical resection between October 2018 and January 2020 in our hospital were retrospectively analyzed. An initial 5-cm periumbilical transverse incision was made. Then, a multiport device was placed in the umbilical incision. Two 10-mm ports were used for laparoscope insertion, and the other two ports were used for laparoscope device insertion. A 12-mm trocar was placed in the right lower abdominal quadrant under laparoscopic view and served as the surgeon’s dominant operating channel. Results All operations were performed successfully without conversion to conventional laparoscopic surgery or open operation. Three patients developed postoperative complications: one patient developed ileus, one developed postoperative bleeding, and one developed wound infection. There were no perioperative deaths. Conclusions The safety and feasibility of SILS+1 radical resection of sigmoid and upper rectal cancer was established by experienced surgeons in our study. However, further studies are needed to demonstrate the advantages of this procedure compared with the benefits of conventional laparoscopic surgery.
机译:目的评价单切口腹腔镜手术+ 1(SILS + 1)根治性切除乙型和上直肠癌的安全性和可行性。方法回顾性分析了2018年10月和2012年1月20日期间的SILS + 1激进切除术的30例连续六连续直肠癌患者的临床资料。制备了初始的5cm periumbilical横切口。然后,将多端口器件放置在脐带切口中。两个10毫米端口用于腹腔镜插入,另外两个端口用于腹腔镜装置插入。在腹腔镜视图下,将12毫米套管针置于右下腹部象限,并作为外科医生的主导操作渠道。结果所有操作均成功进行,无转化为常规腹腔镜手术或开放操作。三名患者开发出术后并发症:一名患者开发了Ileus,一个术后出血,一个发达的伤口感染。没有围手术期死亡。结论我们研究的经验丰富的外科医生建立了SILS + 1乙醇和上直肠癌癌症的安全性和可行性。然而,与常规腹腔镜手术的益处相比,需要进一步的研究来证明该程序的优点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号